Posaconazole
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Posaconazole and local guidelines before prescribing.
Triazole antifungal
Mechanism
Triazole inhibiting ergosterol synthesis.
Uses
Antifungal prophylaxis in leukaemia and transplant, invasive aspergillosis, mucormycosis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, diarrhoea, QT prolongation, raised LFT.
Interactions
Strong CYP3A4 inhibitor; QT-prolonging drugs; PPIs reduce absorption of suspension.
Contraindications and cautions
QT prolongation
Monitoring
Trough level, LFT, ECG
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Caution in severe hepatic impairment
Overdose and reversal
Supportive
Special advice
Take with fatty meal; trough levels.
More from the textbook: uses, cautions and other points
- Infection prophylaxis in intensive treatment - antivirals (aciclovir), co-trimoxazole (PCP), antifungals (posaconazole - many interactions); screen for hepatitis B before rituximab and chemotherapy.
Haematology: Anatomy Physiology and Pharmacology - Antifungal - e.g. posaconazole in AML induction (interacts with venetoclax and others).
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - Posaconazole , isavuconazole | Prophylaxis in AML and GvHD (posaconazole); invasive mould infections; mucormycosis | Levels (posaconazole); interactions (especially with chemotherapy and immunosuppressants)
ID: How Infection Happens - Voriconazole , posaconazole | Trough after about 5–7 days | Wide variation in levels (genetics, interactions); toxicity and failure
ID: How Infection Happens - Invasive aspergillosis | Neutropenia (leukaemia), stem cell and organ transplants, high-dose steroids, severe influenza or COVID-19 in ICU | Fever despite antibiotics, cough, pleuritic pain, haemoptysis; CT nodules with a " halo sign "; galactomannan (blood, BAL); voriconazole or isavuconazole (liposomal amphotericin as an alternative); …
ID: Viral, fungal and parasitic infections - CYP3A4 interactions - inhibitors raise levels (toxicity) - clarithromycin , erythromycin, azole antifungals (fluconazole, voriconazole, posaconazole), diltiazem, verapamil, grapefruit, some HIV drugs; inducers lower levels (rejection) - rifampicin , carbamazepine, phenytoin, St John's wort.
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology - Azoles | Inhibit ergosterol synthesis (14α-demethylase - CYP450) | Fluconazole (Candida, Cryptococcus; no mould activity ), itraconazole, voriconazole (Aspergillus first line - visual disturbance, photosensitivity, skin cancer, hepatitis), posaconazole, isavuconazole; clotrimazole, miconazole (topical) | CYP3A4 inhibitors - major …
Microbiology: Fungi, parasites and travel-related infection - Emergency - urgent surgical debridement , high-dose liposomal amphotericin , correct DKA and reduce immunosuppression; isavuconazole or posaconazole to step down. Voriconazole doesn't work.
ID: Viral, fungal and parasitic infections
Where it is discussed in the book
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (1 mention)
- ID: How Infection Happens (2 mentions)
- ID: Viral, fungal and parasitic infections (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)
- Microbiology: Fungi, parasites and travel-related infection (1 mention)